Immunosuppressive Treatment for Proliferative Lupus Nephritis

    June 2018 in “ Cochrane library
    David J. Tunnicliffe, Suetonia C. Palmer, Lorna Henderson, Philip Masson, Jonathan C. Craig, Allison Tong, Davinder Singh‐Grewal, Robert S Flanc, Matthew A. Roberts, Angela C Webster, Giovanni FM Strippoli
    Studysummary This review update suggests that mycophenolate mofetil may increase complete disease remission in proliferative lupus nephritis compared to intravenous cyclophosphamide, but with low certainty of evidence.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results